FDA Warning Wire: Dr. Reddy's, DNA4Life, Cholesterol Pills
The U.S. Food and Drug Administration recently sent warning letters to some high-profile companies: Indian generic-drug maker Dr. Reddy's was targeted for quality issues at three manufacturing facilities in India while...To view the full article, register now.
Already a subscriber? Click here to view full article